Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic obstructive pulmonary disease (COPD)
Biotech
Pneumagen's flu antiviral stands up to human challenge study
Pneumagen’s Neumifil cut the symptomatic infection rate and severity of viral respiratory tract infections during a phase 2 proof-of-concept trial.
Annalee Armstrong
Oct 2, 2023 4:00am
Study sees COPD patients' breathing boosted by hands-free device
Mar 10, 2023 4:30pm
AstraZeneca beefs up COPD pipeline with $400M biobuck bet
Nov 28, 2022 6:25am
Boehringer's rewards app boosts COPD medication adherence
Aug 10, 2022 12:03pm
Verona's COPD drug hits goal in phase 3, teeing up FDA filing
Aug 9, 2022 6:40am
Penn scientists discover new cell type in the lung
Apr 5, 2022 8:30am